Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.70% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
SBFM · Jun 30, 2025
Sunshine Biopharma Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001683168-25-005981General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-13.53% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
1.15% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
138.35% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
36.37% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-21.83% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.09% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History30 statesSelf-history eligible
Dec 31, 20214/7 normalizedLevel 3Mar 31, 20225/6 normalizedLevel 3Jun 30, 20226/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/7 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/7 normalizedLevel 3Dec 31, 20236/7 normalizedLevel 3Mar 31, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedLevel 3Jun 30, 20246/6 normalizedAmended as filedSep 30, 20246/6 normalizedLevel 3Dec 31, 20247/7 normalizedLevel 3Mar 31, 20257/7 normalizedLevel 3Jun 30, 20257/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20257/7 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.08%
- Current
- 1.70%
- Delta
- 1.62%
- Previous
- -19.25%
- Current
- -13.53%
- Delta
- 5.72%
- Previous
- 18.04%
- Current
- 1.15%
- Delta
- -16.89%
- Previous
- 133.21%
- Current
- 138.35%
- Delta
- 5.14%
- Previous
- 30.67%
- Current
- 36.37%
- Delta
- 5.70%
- Previous
- -14.56%
- Current
- -21.83%
- Delta
- -7.28%
- Previous
- 2.42%
- Current
- 2.09%
- Delta
- -0.33%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · SBFM Fundamental State →Transitioned To · SBFM Fundamental State →Transitioned To · SBFM CAPEX_INTENSITY_INCREASED →Transitioned To · SBFM CASH_GENERATION_INCREASED →Transitioned To · SBFM GROWTH_DECREASED →Transitioned To · SBFM INVENTORY_PRESSURE_INCREASED →Transitioned To · SBFM MARGIN_INCREASED →Transitioned To · SBFM PROFITABILITY_DECREASED →Transitioned To · SBFM R_AND_D_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.